{"id":1070,"date":"2025-06-20T12:55:13","date_gmt":"2025-06-20T11:55:13","guid":{"rendered":"https:\/\/microregistrar.com\/?p=1070"},"modified":"2025-06-20T12:55:14","modified_gmt":"2025-06-20T11:55:14","slug":"cryptococcus-microregistrar-moodlecloud","status":"publish","type":"post","link":"https:\/\/microregistrar.com\/?p=1070","title":{"rendered":"Cryptococcus (microregistrar.moodlecloud)"},"content":{"rendered":"\n<!-- WordPress Post Content - Copy this into your WordPress editor -->\n\n<style>\n.crypto-container {\n    max-width: 100%;\n    margin: 20px 0;\n    font-family: Arial, sans-serif;\n}\n\n.crypto-header {\n    background: linear-gradient(135deg, #2c3e50, #3498db);\n    color: white;\n    padding: 30px;\n    text-align: center;\n    border-radius: 15px;\n    margin-bottom: 30px;\n}\n\n.crypto-header h1 {\n    font-size: 2.2em;\n    margin-bottom: 10px;\n    font-weight: 300;\n}\n\n.crypto-header p {\n    font-size: 1.1em;\n    opacity: 0.9;\n}\n\n.syndrome-grid {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));\n    gap: 20px;\n    margin-bottom: 30px;\n}\n\n.syndrome-card {\n    border: 3px solid #3498db;\n    border-radius: 15px;\n    padding: 20px;\n    background: #f8f9fa;\n    text-align: center;\n}\n\n.syndrome-card h3 {\n    color: #2c3e50;\n    font-size: 1.3em;\n    margin-bottom: 15px;\n    font-weight: 600;\n}\n\n.patient-types {\n    display: flex;\n    flex-wrap: wrap;\n    gap: 8px;\n    justify-content: center;\n    margin-bottom: 15px;\n}\n\n.patient-type {\n    background: #3498db;\n    color: white;\n    padding: 6px 12px;\n    border-radius: 15px;\n    font-size: 0.85em;\n    font-weight: 500;\n}\n\n.patient-type.special {\n    background: #e74c3c;\n}\n\n.treatment-box {\n    background: linear-gradient(135deg, #ff6b6b, #ee5a24);\n    color: white;\n    padding: 25px;\n    border-radius: 15px;\n    margin: 25px 0;\n    box-shadow: 0 8px 16px rgba(238, 90, 36, 0.3);\n}\n\n.treatment-box h4 {\n    font-size: 1.3em;\n    margin-bottom: 15px;\n    text-align: center;\n    font-weight: 600;\n}\n\n.treatment-option {\n    background: rgba(255,255,255,0.15);\n    padding: 15px;\n    border-radius: 10px;\n    margin: 12px 0;\n    border-left: 4px solid #fff;\n}\n\n.treatment-option strong {\n    display: block;\n    margin-bottom: 8px;\n    font-size: 1.05em;\n}\n\n.phase-timeline {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));\n    gap: 20px;\n    margin: 30px 0;\n}\n\n.phase {\n    background: #ecf0f1;\n    border-radius: 15px;\n    padding: 20px;\n    text-align: center;\n    border-top: 5px solid #3498db;\n}\n\n.phase.induction { border-top-color: #e74c3c; }\n.phase.consolidation { border-top-color: #f39c12; }\n.phase.maintenance { border-top-color: #27ae60; }\n\n.phase h4 {\n    color: #2c3e50;\n    font-size: 1.3em;\n    margin-bottom: 15px;\n}\n\n.duration-grid {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));\n    gap: 10px;\n    margin: 15px 0;\n}\n\n.duration-item {\n    background: #3498db;\n    color: white;\n    padding: 12px 8px;\n    border-radius: 8px;\n    text-align: center;\n    font-size: 0.9em;\n    font-weight: 500;\n}\n\n.duration-item.severe { background: #e74c3c; }\n.duration-item.mild { background: #27ae60; }\n\n.grade-legend {\n    display: flex;\n    justify-content: center;\n    flex-wrap: wrap;\n    gap: 25px;\n    margin: 25px 0;\n    padding: 20px;\n    background: #f8f9fa;\n    border-radius: 12px;\n}\n\n.grade-item {\n    display: flex;\n    align-items: center;\n    gap: 10px;\n}\n\n.grade-box {\n    width: 35px;\n    height: 35px;\n    border-radius: 6px;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    color: white;\n    font-weight: bold;\n    font-size: 1.1em;\n}\n\n.grade-a { background: #27ae60; }\n.grade-b { background: #f39c12; }\n\n.special-considerations {\n    background: linear-gradient(135deg, #6c5ce7, #a29bfe);\n    color: white;\n    padding: 25px;\n    border-radius: 15px;\n    margin-top: 30px;\n}\n\n.special-considerations h4 {\n    font-size: 1.4em;\n    margin-bottom: 20px;\n    text-align: center;\n}\n\n.considerations-grid {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));\n    gap: 15px;\n}\n\n.consideration-item {\n    background: rgba(255,255,255,0.15);\n    padding: 15px;\n    border-radius: 10px;\n    border-left: 4px solid #fff;\n}\n\n.consideration-item strong {\n    display: block;\n    margin-bottom: 8px;\n    font-size: 1.05em;\n}\n\n.arrow-down {\n    text-align: center;\n    font-size: 2.5em;\n    color: #3498db;\n    margin: 15px 0;\n}\n\n.wp-caption {\n    font-style: italic;\n    text-align: center;\n    margin: 20px 0;\n    color: #666;\n}\n\n@media (max-width: 768px) {\n    .syndrome-grid {\n        grid-template-columns: 1fr;\n    }\n    \n    .phase-timeline {\n        grid-template-columns: 1fr;\n    }\n    \n    .grade-legend {\n        flex-direction: column;\n        gap: 15px;\n    }\n    \n    .crypto-header h1 {\n        font-size: 1.8em;\n    }\n    \n    .patient-types {\n        justify-content: center;\n    }\n}\n<\/style>\n\n<div class=\"crypto-container\">\n    <div class=\"crypto-header\">\n        <h1>\ud83e\udda0 Cryptococcosis Treatment Algorithm<\/h1>\n        <p>Global Guidelines for Diagnosis and Management | Evidence-Based Recommendations<\/p>\n    <\/div>\n    \n    <div class=\"wp-caption\">\n        <em>Based on the Global Guideline for the Diagnosis and Management of Cryptococcosis (Lancet Infectious Diseases, 2024)<\/em>\n    <\/div>\n    \n    <!-- Clinical Syndromes -->\n    <div class=\"syndrome-grid\">\n        <div class=\"syndrome-card\">\n            <h3>\ud83e\udde0 CNS Cryptococcosis<\/h3>\n            <div class=\"patient-types\">\n                <span class=\"patient-type\">HIV<\/span>\n                <span class=\"patient-type\">SOT<\/span>\n                <span class=\"patient-type\">Non-HIV\/Non-SOT<\/span>\n                <span class=\"patient-type special\">C. gattii<\/span>\n                <span class=\"patient-type special\">Cryptococcoma<\/span>\n            <\/div>\n        <\/div>\n        \n        <div class=\"syndrome-card\">\n            <h3>\ud83d\udd04 Disseminated Disease<\/h3>\n            <p>(Non-CNS\/Non-pulmonary)<\/p>\n        <\/div>\n        \n        <div class=\"syndrome-card\">\n            <h3>\ud83e\udec1 Pulmonary Disease<\/h3>\n            <div class=\"patient-types\">\n                <span class=\"patient-type\">Severe<\/span>\n                <span class=\"patient-type\">Mild<\/span>\n            <\/div>\n            <p>With\/Without Cryptococcoma<\/p>\n        <\/div>\n        \n        <div class=\"syndrome-card\">\n            <h3>\ud83e\ude79 Direct Skin Inoculation<\/h3>\n            <p>Cutaneous infection<\/p>\n        <\/div>\n    <\/div>\n    \n    <!-- Primary Treatment -->\n    <div class=\"treatment-box\">\n        <h4>\ud83d\udc8a PRIMARY INDUCTION THERAPY<\/h4>\n        <div class=\"treatment-option\">\n            <strong>\ud83c\udfe5 High-Income Settings (AIIt):<\/strong>\n            Liposomal Amphotericin B 3-4 mg\/kg daily + Flucytosine 25 mg\/kg four times daily\n        <\/div>\n        <div class=\"treatment-option\">\n            <strong>\ud83c\udf0d Low-Income Settings (AI):<\/strong>\n            Single-dose Liposomal AmB 10 mg\/kg + Flucytosine 25 mg\/kg four times daily + Fluconazole 1200 mg daily \u00d7 14 days\n        <\/div>\n    <\/div>\n    \n    <div class=\"arrow-down\">\u2b07\ufe0f<\/div>\n    \n    <!-- Treatment Phases -->\n    <div class=\"phase-timeline\">\n        <div class=\"phase induction\">\n            <h4>\ud83c\udfaf INDUCTION PHASE<\/h4>\n            <div class=\"duration-grid\">\n                <div class=\"duration-item\">HIV: 2 weeks<\/div>\n                <div class=\"duration-item\">SOT: \u22652 weeks<\/div>\n                <div class=\"duration-item\">Non-HIV: \u22652 weeks<\/div>\n                <div class=\"duration-item severe\">C. gattii: 4-6 weeks<\/div>\n                <div class=\"duration-item severe\">Cryptococcoma: 4-6 weeks<\/div>\n            <\/div>\n        <\/div>\n        \n        <div class=\"phase consolidation\">\n            <h4>\ud83d\udd04 CONSOLIDATION PHASE<\/h4>\n            <p><strong>Fluconazole 400-800 mg daily<\/strong><\/p>\n            <p>Duration: <strong>8 weeks<\/strong><\/p>\n            <p><em>(800 mg preferred in low-income settings)<\/em><\/p>\n        <\/div>\n        \n        <div class=\"phase maintenance\">\n            <h4>\ud83d\udee1\ufe0f MAINTENANCE PHASE<\/h4>\n            <p><strong>Fluconazole 200 mg daily<\/strong><\/p>\n            <p>Duration: <strong>12 months<\/strong><\/p>\n            <p><em>(Until immune restoration)<\/em><\/p>\n        <\/div>\n    <\/div>\n    \n    <!-- Specific Disease Durations -->\n    <h3>\ud83d\udccb Treatment Durations by Disease Type<\/h3>\n    <div class=\"duration-grid\">\n        <div class=\"duration-item\">\ud83d\udd04 Disseminated: 2 weeks<\/div>\n        <div class=\"duration-item severe\">\ud83e\udec1 Severe Pulmonary: 2 weeks<\/div>\n        <div class=\"duration-item severe\">\ud83e\udec1 With Cryptococcoma: 4-6 weeks<\/div>\n        <div class=\"duration-item mild\">\ud83e\udec1 Mild Pulmonary: 6-12 months<\/div>\n        <div class=\"duration-item mild\">\ud83e\ude79 Skin Inoculation: 3-6 months<\/div>\n    <\/div>\n    \n    <!-- Evidence Grades -->\n    <div class=\"grade-legend\">\n        <div class=\"grade-item\">\n            <div class=\"grade-box grade-a\">A<\/div>\n            <span><strong>Strongly Recommended<\/strong> &#8211; High-quality evidence<\/span>\n        <\/div>\n        <div class=\"grade-item\">\n            <div class=\"grade-box grade-b\">B<\/div>\n            <span><strong>Moderately Recommended<\/strong> &#8211; Moderate-quality evidence<\/span>\n        <\/div>\n    <\/div>\n    \n    <!-- Special Considerations -->\n    <div class=\"special-considerations\">\n        <h4>\u26a0\ufe0f CRITICAL MANAGEMENT POINTS<\/h4>\n        <div class=\"considerations-grid\">\n            <div class=\"consideration-item\">\n                <strong>\ud83e\udda0 HIV Patients:<\/strong><br>\n                \u2022 Delay ART initiation 4-6 weeks<br>\n                \u2022 Monitor for C-IRIS<br>\n                \u2022 Screen with CrAg if CD4 <200<br>\n                \u2022 Therapeutic lumbar punctures for \u2191ICP\n            <\/div>\n            <div class=\"consideration-item\">\n                <strong>\ud83c\udfe5 SOT Recipients:<\/strong><br>\n                \u2022 Therapeutic drug monitoring for calcineurin inhibitors<br>\n                \u2022 Carefully adjust immunosuppression<br>\n                \u2022 Monitor for drug-drug interactions<br>\n                \u2022 Extended treatment duration\n            <\/div>\n            <div class=\"consideration-item\">\n                <strong>\ud83e\udde0 Raised Intracranial Pressure:<\/strong><br>\n                \u2022 Therapeutic lumbar punctures if pressure \u226520 cm CSF<br>\n                \u2022 Remove CSF to reduce pressure by 50%<br>\n                \u2022 Surgical drainage if refractory<br>\n                \u2022 Avoid acetazolamide, mannitol\n            <\/div>\n            <div class=\"consideration-item\">\n                <strong>\ud83d\udd2c Drug Monitoring:<\/strong><br>\n                \u2022 CBC, renal function, electrolytes q48h<br>\n                \u2022 Pre-hydration with amphotericin B<br>\n                \u2022 Aggressive K+ and Mg2+ replacement<br>\n                \u2022 Flucytosine levels if available\n            <\/div>\n            <div class=\"consideration-item\">\n                <strong>\ud83e\udd30 Pregnancy Considerations:<\/strong><br>\n                \u2022 Amphotericin B formulations are safe<br>\n                \u2022 Avoid flucytosine (Category C)<br>\n                \u2022 Avoid fluconazole (Category D)<br>\n                \u2022 Especially avoid in first trimester\n            <\/div>\n            <div class=\"consideration-item\">\n                <strong>\ud83d\udc76 Pediatric Dosing:<\/strong><br>\n                \u2022 AmB 1 mg\/kg or liposomal AmB 3-4 mg\/kg<br>\n                \u2022 Flucytosine 100-150 mg\/kg\/day in 4 doses<br>\n                \u2022 Fluconazole 12 mg\/kg daily (max 800 mg)<br>\n                \u2022 Weight-based calculations essential\n            <\/div>\n        <\/div>\n    <\/div>\n    \n    <div class=\"wp-caption\">\n        <em><strong>Abbreviations:<\/strong> AmB = Amphotericin B; SOT = Solid Organ Transplant; C-IRIS = Cryptococcosis-associated Immune Reconstitution Inflammatory Syndrome; ICP = Intracranial Pressure; CrAg = Cryptococcal Antigen; CBC = Complete Blood Count<\/em>\n    <\/div>\n<\/div>\n\n<!-- WordPress Post Text Content Below -->\n\n<h2>Key Clinical Pearls<\/h2>\n\n<ul>\n<li><strong>Early Recognition:<\/strong> Consider cryptococcosis in any immunocompromised patient with compatible symptoms, regardless of HIV status<\/li>\n<li><strong>Lumbar Puncture is Essential:<\/strong> All patients with suspected cryptococcosis require LP with opening pressure measurement<\/li>\n<li><strong>Combination Therapy Superior:<\/strong> Amphotericin B + flucytosine combination shows superior early fungicidal activity compared to monotherapy<\/li>\n<li><strong>Pressure Management Critical:<\/strong> Raised intracranial pressure is a major cause of morbidity and mortality &#8211; aggressive management with therapeutic LPs is essential<\/li>\n<li><strong>ART Timing Matters:<\/strong> In HIV patients, delaying ART initiation by 4-6 weeks reduces C-IRIS risk and improves outcomes<\/li>\n<\/ul>\n\n<h2>Clinical Decision Making<\/h2>\n\n<p>This algorithm represents a synthesis of evidence from multiple randomized controlled trials and expert consensus from over 70 international medical societies. Treatment decisions should always be individualized based on:<\/p>\n\n<ul>\n<li>Patient immune status and comorbidities<\/li>\n<li>Disease severity and extent<\/li>\n<li>Local antifungal availability and resources<\/li>\n<li>Potential drug interactions and contraindications<\/li>\n<li>Monitoring capabilities<\/li>\n<\/ul>\n\n<h2>When to Consult Specialists<\/h2>\n\n<ul>\n<li><strong>Infectious Disease:<\/strong> All cases of cryptococcosis<\/li>\n<li><strong>Neurosurgery:<\/strong> Refractory increased intracranial pressure<\/li>\n<li><strong>Ophthalmology:<\/strong> Visual changes or suspected ocular involvement<\/li>\n<li><strong>Clinical Immunology:<\/strong> Cryptococcosis in apparently immunocompetent patients<\/li>\n<\/ul>\n\n<blockquote>\n<p><strong>Remember:<\/strong> Cryptococcosis remains a medical emergency with high mortality. Early recognition, prompt initiation of appropriate antifungal therapy, and aggressive management of complications are crucial for optimal outcomes.<\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>\ud83e\udda0 Cryptococcosis Treatment Algorithm Global Guidelines for Diagnosis and Management | Evidence-Based Recommendations Based on the Global Guideline for the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ngg_post_thumbnail":0,"footnotes":""},"categories":[12],"tags":[206],"class_list":["post-1070","post","type-post","status-publish","format-standard","hentry","category-mycology","tag-cryptococcus"],"_links":{"self":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1070"}],"version-history":[{"count":1,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1070\/revisions"}],"predecessor-version":[{"id":1071,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1070\/revisions\/1071"}],"wp:attachment":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}